Health & Medical Endocrine disease

Need and Disparities in Management of Patients With Diabetes

Need and Disparities in Management of Patients With Diabetes

Discussion


This population-based Italian study estimated the prevalence of diabetes in the general population. Our prevalence estimates, calculated on subjects aged 16 or more, resemble those reported by the national public health system's service for the ongoing surveillance of the adult population, developed by the Italian National Health Institute (Istituto Superiore di Sanità, ISS), which reported a prevalence of 4.96% in the population aged 18–69y in 2009, and the Italian Statistics Institute (ISTAT) indicated an overall 4.8% prevalence of diabetes in 2008. The populations investigated in these various estimates differed in age of enrollment and the methods used to identify cases of diabetes were also quite different: the present study relied on record-linkage administrative data, whereas the other above-mentioned statistics were based on telephone and personal interviews, respectively, indicating self-reported diagnoses of diabetes.

The prevalence of diabetes by age group in our sample was similar to the findings of a study on the prevalence of diabetes in eight European countries, and in the US. The prevalence of the disease decreased in older age, probably due to the longer survival of non-diabetic people or to a cohort effect. There was also gender-related difference, with a higher prevalence of the disease in males than in females (especially among the older adults). These results echo previous prevalence estimates conducted in Europe, in the USA (for diagnosed and undiagnosed diabetes) and in a number of other countries.

Our results also indicated that immigrants from HMPC have a higher prevalence of diabetes than native Italians, as reported in other studies conducted in Israel and in the US National Estimates on Diabetes (this report did not consider immigrant status, but it showed that Blacks and Hispanics have higher rates of diabetes than Whites).

The present study showed that almost 40% of the whole diabetic population in Italy was not monitored annually in terms of HbA1c, LDL or creatinine levels. Only a few cross-sectional studies in Europe provide details on the care process at population level. In a UK population of patients with diabetes, an HbA1c test had been done within the previous year in 93.5% of cases, a serum cholesterol test in 93.1%, and a creatinine test in 93.8%. Another study in Israel found that the care delivered by the health services ensured that almost 85% of patients had annual HbA1c and serum cholesterol tests. Our results are very similar to those reported in the USA for Medicare beneficiaries on two quality measures (annual HbA1c testing and lipid profile measurements), and to the findings of a previous survey conducted in the Italian city of Torino. The differences in process performance between different countries may stem from the way in which primary care is organized and motivated, showing better results in countries where 'pay for performance' in primary care schemes are in place, as in the UK. After a quarter of the income of family practitioners in the UK was tied to measures of their performance, the Quality and Outcomes Framework showed that previously-identified quality improvement trends for major chronic conditions were maintained or increased, but the effect plateaued as physicians gained the maximum rewards available. For major chronic conditions like diabetes, financial incentives should be seen as part of a broader quality improvement strategy. This philosophy is consistent with the general literature on quality improvement, which suggests that there is no "magic bullet", but multiple interventions sustained over time can produce major improvements in care. Other issues may also help to explain the differences in process performance between different countries, such as a different reliance on of multidisciplinary primary healthcare teams, which are important in empowering patients and supporting their day-to-day self-management, different methods for training diabetics and their key carers to maintain effective self-management and monitoring. The differences in performance in different countries should encourage international cooperation to facilitate the exchange of good practice for the purpose of controlling diabetes by creating a diabetes forum for action and monitoring.

The present study also aimed to identify disparities in the delivery of care to diabetes patients and it emerged that gender, age, comorbidities, citizenship and time since diagnosis were all independent variables explaining differences in the management of this disease.

The role of education and economic status in disparities in diabetes patients management is still being debated in the literature. In the present study, we looked instead at the influence of citizenship, gender and age. Our data show that immigration from a HMPC reduces the likelihood of a patient's diabetes being monitored, as shown in another study based on the VALORE project. Other studies detected racial and ethnic differences in the quality of diabetes care too. It has also already been demonstrated that immigrants make less use of primary care and are less inclined to contact primary care physicians, who are the most often involved in the management of diabetes.

Our data indicate that age is a strong factor influencing the management of diabetes care, irrespective of the duration of the disease and any comorbidities. The elderly and younger adults are less likely to be monitored (an abnormal decline in the quality of care for elderly patients has also been reported in some, but not all other studies). This has nothing to do with the availability of evidence-based care, and probably relates to the propensity of individuals to seek primary care, as demonstrated in a previous study. Younger adults are likely to be busier in occupational terms and child care, and less likely to get in touch with their doctors, while the elderly are probably less able to reach a physician unassisted. Primary care physicians could provide a more proactive service and actively seek such patients out. These considerations identify a challenge for society and health care organizations to find solutions for any "unequal management" issues. A study on the impact of a major pay-for-performance initiative introduced in the UK primary care services in 2004 (which was expected to promote more proactive health care services) suggested that younger patients (<45 years old) with diabetes benefited less in terms of performance quality and outcomes than older patients, i.e. some age group disparities persisted.

Gender differences in adherence to process performance measures were small, but emerged consistently for all processes indicators. Other authors have reported a higher proportion of females receiving optimal follow-up than males, and one study found gender differences for diabetes patients also in terms of GP appointments and prescribed medication, again in favor of female gender. This better diabetes management in women could be partly explained by the gender-related difference in the outcome of the disease, which is known to carry a lower CVD- and CHD-related mortality risk for men than for women (though the processes measured concern the minimum recommended for all patients).

Patients whose diabetes had been diagnosed less than 3 years earlier were monitored more carefully than patients with a longer history of disease. This applied to all the indicators considered, and to HbA1c testing in particular. This might be because patients with a relatively recent diagnosis are more likely to have difficulty in controlling their disease parameters and consequently need to be monitored more closely. Alternatively, patients with a more longstanding disease might be less concerned about their diabetes and less compliant with their doctor's recommendations because their clinical condition has become stable, giving the impression that they would need monitoring less frequently. The recommended minimal tests for monitoring diabetes should nonetheless be offered to all patients, irrespective of how long they have been known to have diabetes.

The present study shows that patients with high comorbidity rates were monitored less thoroughly in terms of HbA1c and LDL tests, than those with no comorbidities. Another study also found that a cardiovascular event, for example, distracts the doctor's and patient's attention from the need to monitor their diabetes. The onset of other medical issues and the arrival on the scene of other specialists (less sensitive to the diabetes issue) might plausibly diminish the intensity of diabetes screening.

The main drawback of the present study lies in that it cannot separate the effects of socio-demographic determinants on diabetes management, distinguishing between the influence of patients' socio-demographic features on their different degrees of adherence to the prescribed monitoring practices on the one hand, and differences in physicians' monitoring practices depending on their patients' socio-demographic features on the other. Although different strategies would be needed to tackle these two possible causes of shortcomings in health care provision, the message that comes from the present study – that efforts are needed to overcome inequalities in diabetes patient management - is important, whatever the causal factors involved and their relative contributions.

Our study has other limitations. First of all, not all socio-economics factors were considered (patients' formal education was not known, for instance). Secondly, only process measures were assessed in the present study, but whether or not closer monitoring is necessarily linked to better intermediate or final outcomes for diabetes patients is still being debated. One recent study found that patients receiving the lowest-quality care, as measured in terms of the fulfillment of quality-of-care indicators based on screening guidelines similar to those considered here, carried a higher risk of all-cause mortality and cardiovascular morbidity than those receiving the highest-quality care. Another possible shortcoming of our study lies in that using record linkage may have failed to identify some diabetic patients. The validity of our record linkage procedures, based on three administrative sources (records of hospital discharges, drug prescriptions and payment exemptions for chronic diseases) was addressed in two recent studies. Both reported that these routinely-collected data enable disease prevalence to be estimated just as accurately as in other studies conducted in Italy using more costly and time-consuming methods. Another recent study showed that using an additional source (the Diabetes Service's integrated database) led to the identification of a higher proportion of diabetics, particularly among the elderly. This could be because patients whose condition is treated with lifestyle management alone will not be identifiable from the administrative databases unless they have applied for a disease-specific exemption from healthcare co-payment. Elderly diabetics living in rest homes would also go undetected because rest homes obtain and distribute any drugs needed by residents without using prescriptions for named patients. Measures of compliance with standards of care have shown, however, that these rest home residents receive much the same care as the population identified from clinical data collected by general practitioners.

The strength of our study lies in that it was conducted using an unrestricted and unselected population of primary care patients with diabetes mellitus, enabling us to estimate the prevalence of the disease and primary care performance measures.

You might also like on "Health & Medical"

Leave a reply